Qube Research & Technologies (QRT)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $516K | Sell |
38,677
-234,665
| -86% | -$3.13M | ﹤0.01% | 1970 |
|
|
2025
Q1 | $2.79M | Buy |
+273,342
| New | +$2.79M | ﹤0.01% | 1432 |
|
|
2024
Q4 | – | Sell |
-27,941
| Closed | -$1.62M | – | 2944 |
|
|
2024
Q3 | $1.62M | Sell |
27,941
-3,294
| -11% | -$191K | ﹤0.01% | 1494 |
|
|
2024
Q2 | $1.43M | Buy |
31,235
+28,973
| +1,281% | +$1.32M | ﹤0.01% | 1482 |
|
|
2024
Q1 | $150K | Sell |
2,262
-32,280
| -93% | -$2.14M | ﹤0.01% | 2685 |
|
|
2023
Q4 | $1.37M | Buy |
34,542
+25,584
| +286% | +$1.02M | ﹤0.01% | 1475 |
|
|
2023
Q3 | $286K | Sell |
8,958
-17,880
| -67% | -$570K | ﹤0.01% | 1876 |
|
|
2023
Q2 | $1.08M | Sell |
26,838
-10,773
| -29% | -$433K | ﹤0.01% | 1200 |
|
|
2023
Q1 | $1.61M | Buy |
37,611
+24,631
| +190% | +$1.05M | 0.01% | 1045 |
|
|
2022
Q4 | $623K | Sell |
12,980
-9,036
| -41% | -$434K | ﹤0.01% | 1326 |
|
|
2022
Q3 | $828K | Sell |
22,016
-32,015
| -59% | -$1.2M | ﹤0.01% | 1220 |
|
|
2022
Q2 | $1.49M | Buy |
+54,031
| New | +$1.49M | 0.01% | 923 |
|